Mereo BioPharma (MREO) Enterprise Value (2017 - 2026)
Mereo BioPharma (MREO) reported Enterprise Value of -$36.2 million for Q1 2026, up 42.04% year-over-year from -$25.5 million in Q1 2025, and up 11.63% quarter-over-quarter from -$41.0 million in Q4 2025.
Mereo BioPharma (MREO) Enterprise Value (2017 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 10 years of Enterprise Value data on file, last reported at -$36.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$36.2 million, up 42.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.2 million (up 42.04% YoY), and the FY2025 annual result was -$41.0 million, up 41.27% from the prior year.
- Enterprise Value improved to -$36.2 million in Q1 2026 per MREO's latest filing, from -$41.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$36.2 million in Q1 2026 and troughed at -$87.4 million in Q2 2024.
- A 5-year average of -$59.5 million and a median of -$57.4 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 48.02% in 2022, then retreated 28.44% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$66.1 million in 2022, then increased by 13.1% to -$57.4 million in 2023, then declined by 21.56% to -$69.8 million in 2024, then jumped by 41.27% to -$41.0 million in 2025, then advanced by 11.63% to -$36.2 million in 2026.
- Business Quant data shows MREO's Enterprise Value at -$36.2 million in Q1 2026, -$41.0 million in Q4 2025, and -$48.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -36.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.22 Mn |
| Dec 31, 2025 | -40.99 Mn |
| Sep 30, 2025 | -48.70 Mn |
| Jun 30, 2025 | -56.10 Mn |
| Mar 31, 2025 | -62.50 Mn |
| Dec 31, 2024 | -69.80 Mn |
| Sep 30, 2024 | -80.52 Mn |
| Jun 30, 2024 | -87.43 Mn |
| Mar 31, 2024 | -48.66 Mn |
| Dec 31, 2023 | -57.42 Mn |
| Dec 31, 2022 | -66.08 Mn |
| Dec 31, 2021 | -127.11 Mn |
| Dec 31, 2020 | -30.99 Mn |
| Dec 31, 2019 | -21.02 Mn |
| Dec 31, 2018 | -35.44 Mn |
| Dec 31, 2017 | -69.76 Mn |